TENCENT
00700
XIAOMI-W
01810
JD HEALTH
06618
MEITUAN-W
03690
BILIBILI-W
09626
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 25.94%50.53M | ---- | -30.88%40.12M | ---- | -1.45%58.04M | ---- | -43.41%58.9M | ---- | -38.48%104.07M |
Profit adjustment | ||||||||||
Dividend (income)- adjustment | ---- | 30.71%-282K | ---- | -16.95%-407K | ---- | 34.22%-348K | ---- | ---529K | ---- | ---- |
Impairment and provisions: | ---- | -29.41%20.29M | ---- | 37.81%28.74M | ---- | -22.18%20.86M | ---- | -17.88%26.8M | ---- | 183.97%32.63M |
-Other impairments and provisions | ---- | -29.41%20.29M | ---- | 37.81%28.74M | ---- | -22.18%20.86M | ---- | -17.88%26.8M | ---- | 183.97%32.63M |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.62%-305K |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.62%-305K |
Asset sale loss (gain): | ---- | -7,022.22%-3.12M | ---- | 106.89%45K | ---- | -2,020.59%-653K | ---- | -84.68%34K | ---- | 103.67%222K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -7,022.22%-3.12M | ---- | 106.89%45K | ---- | -2,020.59%-653K | ---- | -84.68%34K | ---- | 184.62%222K |
Depreciation and amortization: | ---- | -17.75%15.91M | ---- | 3.11%19.34M | ---- | 6.07%18.76M | ---- | -13.12%17.69M | ---- | 23.81%20.36M |
-Amortization of intangible assets | ---- | -38.43%133K | ---- | 18.68%216K | ---- | -9.00%182K | ---- | -18.37%200K | ---- | -47.31%245K |
Financial expense | ---- | -22.22%16.49M | ---- | 53.26%21.2M | ---- | 9.08%13.83M | ---- | 43.60%12.68M | ---- | -6.68%8.83M |
Exchange Loss (gain) | ---- | 91.69%-582K | ---- | -299.97%-7.01M | ---- | -75.39%3.5M | ---- | 362.46%14.24M | ---- | -537.58%-5.43M |
Operating profit before the change of operating capital | ---- | -2.74%99.23M | ---- | -10.49%102.03M | ---- | -12.19%113.99M | ---- | -19.06%129.81M | ---- | -22.49%160.38M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -97.03%911K | ---- | 17.80%30.72M | ---- | 170.84%26.07M | ---- | -981.17%-36.8M | ---- | 79.34%-3.4M |
Accounts receivable (increase)decrease | ---- | -299.15%-312.38M | ---- | -288.16%-78.26M | ---- | -86.58%41.59M | ---- | 198.28%309.98M | ---- | -172.81%-315.39M |
Accounts payable increase (decrease) | ---- | 32.53%-89.11M | ---- | -0.32%-132.06M | ---- | -42.92%-131.64M | ---- | -141.94%-92.11M | ---- | -36.27%219.61M |
Special items for working capital changes | ---- | -2.75%107.83M | ---- | 322.78%110.87M | ---- | 81.36%-49.77M | ---- | -2,637.39%-267.04M | ---- | 105.45%10.52M |
Cash from business operations | -16.55%-119.85M | -681.16%-193.51M | 58.99%-102.82M | 13,435.37%33.3M | -161.17%-250.71M | -99.44%246K | -259.45%-95.99M | -38.87%43.85M | -23.55%60.2M | -68.29%71.72M |
Other taxs | 49.22%-7.01M | -127.88%-30.57M | -54.22%-13.8M | 9.02%-13.42M | 17.07%-8.95M | -30.69%-14.75M | 17.01%-10.79M | 68.83%-11.28M | 48.86%-13M | -99.01%-36.21M |
Net cash from operations | -8.77%-126.85M | -1,227.18%-224.08M | 55.08%-116.63M | 237.09%19.88M | -143.16%-259.65M | -144.53%-14.5M | -326.23%-106.78M | -8.31%32.56M | -11.49%47.2M | -82.92%35.51M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -74.35%553K | 153.17%4.55M | 188.62%2.16M | -25.43%1.8M | -44.75%747K | -43.06%2.41M | -60.14%1.35M | -51.43%4.23M | --3.39M | 25.35%8.72M |
Dividend received - investment | -60.87%18K | -30.71%282K | 15.00%46K | 16.95%407K | --40K | -34.22%348K | ---- | --529K | ---- | ---- |
Decrease in deposits (increase) | 201.72%1.83M | ---1.8M | ---1.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | -92.89%208K | 317.02%2.92M | 2,204.72%2.93M | -94.41%699K | -98.71%127K | 1,637.69%12.49M | 65,633.33%9.86M | 409.93%719K | --15K | --141K |
Purchase of fixed assets | -38.80%-3.06M | 4.97%-7.61M | 67.45%-2.2M | 5.92%-8.01M | -65.94%-6.76M | 35.59%-8.51M | -26.16%-4.08M | 36.65%-13.22M | -29.30%-3.23M | -194.86%-20.87M |
Selling intangible assets | ---- | --3.03M | --1.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | ---- | 21.13%-56K | ---- | 0.00%-71K | ---- | ---71K | ---- | ---- | ---- | -8.98%-352K |
Recovery of cash from investments | 2,919.31%39.25M | --1.3M | --1.3M | ---- | ---- | --50K | ---- | ---- | ---- | 42.88%36.07M |
Cash on investment | ---- | ---- | ---- | 48.00%-1.3M | ---1.3M | ---2.5M | ---- | ---- | ---- | 16.37%-21.74M |
Other items in the investment business | ---- | ---- | ---- | -2.04%-25.51M | ---- | 0.00%-25M | ---- | 41.31%-25M | ---- | 70.63%-42.59M |
Net cash from investment operations | 950.23%38.81M | 108.16%2.61M | 151.69%3.7M | -53.92%-31.99M | -200.15%-7.15M | 36.52%-20.78M | 3,932.20%7.14M | 19.43%-32.74M | 106.62%177K | 72.21%-40.63M |
Net cash before financing | 22.03%-88.05M | -1,729.30%-221.47M | 57.67%-112.93M | 65.69%-12.11M | -167.75%-266.8M | -20,061.71%-35.28M | -310.32%-99.65M | 96.58%-175K | -6.47%47.38M | -108.29%-5.12M |
Cash flow from financing activities | ||||||||||
New borrowing | 120.76%257.17M | -8.25%278.37M | -39.10%116.49M | 203.73%303.38M | 282.59%191.29M | --99.89M | 150.00%50M | ---- | 0.00%20M | --25M |
Refund | -0.37%-146.68M | -76.57%-321.11M | -42.58%-146.14M | -516.47%-181.86M | -360.67%-102.5M | -555.56%-29.5M | 0.00%-22.25M | 30.77%-4.5M | ---22.25M | -18.18%-6.5M |
Interest paid - financing | 14.87%-5.18M | -50.54%-12.34M | -64.92%-6.08M | -104.39%-8.2M | -30.94%-3.69M | 25.02%-4.01M | -63.66%-2.82M | 72.50%-5.35M | ---1.72M | -18.69%-19.46M |
Dividends paid - financing | ---- | 36.28%-7.02M | ---- | -100.53%-11.01M | ---- | 75.09%-5.49M | ---- | -146.58%-22.05M | ---- | ---8.94M |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.76M | ---1.99M | ---- |
Net cash from financing operations | 387.19%103.99M | -162.26%-63.21M | -142.74%-36.21M | 71.77%101.51M | 253.81%84.72M | 254.52%59.1M | 438.79%23.95M | -254.13%-38.25M | -135.34%-7.07M | -106.23%-10.8M |
Effect of rate | 86.94%-244K | -96.28%258K | -130.45%-1.87M | 288.53%6.94M | 410.43%6.13M | 61.65%-3.68M | -175.88%-1.98M | -402.75%-9.59M | 330.41%2.6M | 305.24%3.17M |
Net Cash | 110.69%15.94M | -418.41%-284.68M | 18.09%-149.14M | 275.40%89.41M | -140.52%-182.08M | 161.99%23.82M | -287.80%-75.7M | -141.35%-38.42M | -42.95%40.31M | -106.77%-15.92M |
Begining period cash | -52.65%255.75M | 21.71%540.18M | 21.71%540.18M | 4.75%443.83M | 4.75%443.83M | -10.18%423.7M | -10.18%423.7M | -2.63%471.71M | 22.24%471.71M | 94.88%484.46M |
Cash at the end | -30.25%271.45M | -52.65%255.75M | 45.27%389.17M | 21.71%540.18M | -22.58%267.89M | 4.75%443.83M | -32.76%346.02M | -10.18%423.7M | 12.57%514.63M | -2.63%471.71M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.